Evidence check: CYP2C19 in the context of Stress

The evidence for a direct link between CYP2C19 and stress is weak. CYP2C19 is a cytochrome P450 enzyme primarily involved in the metabolism of drugs such as clopidogrel, proton pump inhibitors, and certain antidepressants. Some studies suggest a possible influence of CYP2C19 polymorphisms on cortisol regulation, but the data are inconsistent and largely mechanistic. In practice, CYP2C19 variants are commonly tested in pharmacogenetics to adjust drug dosages – not to assess stress. Consumer DNA tests that include CYP2C19 therefore do not provide meaningful information about individual stress susceptibility or coping. The evidence for a clinically relevant connection between CYP2C19 and stress is insufficient. Caution is advised: such tests may be misinterpreted if marketed as a 'stress gene'. Consultation with a physician or genetic counselor is recommended.